-
Comprehensive Report on the Bone And Joint Health Supplements Market: Opportunities and Challenges
21 Nov 2025 09:30 GMT
… example, in May 2022, Amgen, an American biotechnology firm, released figures showing …
-
2025 Edison Patent Awards honor top NJ innovators, leaders
25 Nov 2025 04:22 GMT
… Visionary Award
President and CEO, Biotechnology Innovation Organization (BIO)
Recognized … winners include:
Avantor & Amgen – Biotechnology
Developed biodegradable, low-toxicity viral … in health care and biotechnology to breakthroughs in communications, …
-
Myelodysplastic Syndrome Drugs Market is Projected to Increase at a CAGR of 9.3% Through 2025-2029
25 Nov 2025 00:00 GMT
… the Myelodysplastic Syndrome Drugs include:
• Amgen Inc.
• Celgene Corporation
• Otsuka Pharmaceutical … . For example, Geron Corporation, a biotechnology firm based in the United …
-
Bioengineered Protein Drugs Market Set to Reach $593.3 Billion by 2029
24 Nov 2025 10:30 GMT
… Drugs include:
• Abbvie Inc.
• Amgen Inc.
• Astrazeneca PLC
• Bayer HealthCare … 2023, Future Fields, a biotechnology company based in Canada, formed … Research Organizations, Research Institutes, Biotechnology Companies
Subsegments:
1) By Recombinant …
-
Eylea Market to Reach $13.64 Billion by 2029 with 6.7% CAGR
24 Nov 2025 10:45 GMT
…
• Roche Holding AG
• Pfizer Inc.
• Amgen Inc.
• Sanofi S.A.
• AbbVie … example, Regeneron Pharmaceuticals, Inc., a biotechnology company based in the US …
-
Zymeworks wanted to be Canada’s first Big Pharma. Despite two blockbusters-in-the-making, that’s no longer the plan
24 Nov 2025 10:14 GMT
… a typical path of a biotechnology company,” Bloom Burton & Co … Big Pharma. Though biotech startups Amgen Inc. and Gilead Sciences Inc …
-
Darbepoetin Alfa (Aranesp) Market CAGR to be at 5% from 2025 to 2029 | $7.37 Billion Industry Revenue by 2029
24 Nov 2025 10:00 GMT
… (Aranesp) include:
• Johnson & Johnson
• Amgen Inc.
• Mylan N.V.
• Teva … ., a UK-based pharmaceutical and biotechnology enterprise, unfolded a new treatment …
-
Tumor Necrosis Factor Inhibitor Drugs Industry Analysis Report 2025: Key Trends, Drivers, and Forecast Insights
24 Nov 2025 00:00 GMT
… Inhibitor Drugs include:
• AbbVie Inc.
• Amgen Inc.
• Johnson & Johnson Services … the US, collaborated with a biotechnology firm from Luxembourg known as …
-
Cancer Immunotherapy Market to Reach USD $189.5 Billion by 2029 at 11.2% CAGR
21 Nov 2025 05:28 GMT
… in the Cancer Immunotherapy include:
• Amgen Inc.
• AstraZeneca PLC
• F. Hoffmann … , AstraZeneca plc, a pharmaceutical and biotechnology firm based in the UK …
-
Enzyme Inhibitor Market - Opportunities, Share, Growth and Competitive Analysis and Forecast 2029
21 Nov 2025 05:22 GMT
… Enzyme Inhibitor include:
• Abbott Laboratories
• Amgen Inc.
• AstraZeneca plc
• Bayer AG …
4) By End User: Pharmaceutical, Biotechnology, Food And Beverage, Other End …
About
© 1995-2025